Journal Articles
Fernandes, Richard G., Khoo, Emi, Harris, Heidi Jensen, Gilmore, Robert, Khaing, Myat Myat, Begun, Jakob and An, Yoon-Kyo (2024). Sa1767 A COST-EFFECTIVE INFLAMMATORY BOWEL DISEASE FLARE MANAGEMENT PATHWAY UTILISING RAPID ACCESS INTESTINAL ULTRASOUND AND NURSE-LED TRIAGE TO ACHIEVE HOSPITAL AVOIDANCE WITH HIGH PATIENT SATISFACTION. Gastroenterology, 166 (5), S-514. doi: 10.1016/s0016-5085(24)01652-4
Gilmore, Robert, Tan, Lian, Fernandes, Richard, An, Yoon-Kyo and Begun, Jakob (2023). Upadacitinib salvage therapy for infliximab experienced patients with acute severe ulcerative colitis. Journal of Crohn's and Colitis, 17 (12), 2033-2036. doi: 10.1093/ecco-jcc/jjad115
Gilmore, Robert, Lo, Sheng W., Cheong, Rachael, Karim, Syeda Tahiya, Farrah, Deborah, Kashkooli, Soleiman, Segal, Jonathan P. and Garg, Mayur (2023). Factors associated with long‐term healthcare expense and steroid exposure in patients admitted with acute severe ulcerative colitis. JGH Open, 7 (7), 482-486. doi: 10.1002/jgh3.12933
Tassone, Daniel, Gilmore, Robert, Lee, Tanya and Ding, Nik S. (2023). Letter: diagnostic delay in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 57 (10), 1203-1204. doi: 10.1111/apt.17483
Gilmore, Robert, Tassone, Daniel and Ding, Nik S. (2023). Letter: tofacitinib in the real world – do clinical trial data stand up?. Alimentary Pharmacology and Therapeutics, 57 (6), 745-746. doi: 10.1111/apt.17402
Lin, Lyman, Gilmore, Robert and Basnayake, Chamara (2023). GI snapshot: weight loss and altered bowel habit in a 72-year-old woman. Gut, 72 (11), gutjnl-2022. doi: 10.1136/gutjnl-2022-329084
Bradbury, Jack, Gilmore, Robert and Garg, Mayur (2022). Multifocal small bowel intussusception: an unusual presentation of a common problem. Gastroenterology, 162 (7), 1844-1846. doi: 10.1053/j.gastro.2022.02.041
Gilmore, Robert B., Taylor, Kirstin M., Morrissey, C. Orla and Gardiner, Bradley J. (2022). Cytomegalovirus in inflammatory bowel disease: a clinical approach. Internal Medicine Journal, 52 (3), 365-368. doi: 10.1111/imj.15085
Srinivasan, Ashish, Gilmore, Robert, van Langenberg, Daniel and De Cruz, Peter (2022). Systematic review and meta-analysis: evaluating response to empiric anti-TNF dose intensification for secondary loss of response in Crohn’s disease. Therapeutic Advances in Gastroenterology, 15 ARTN 17562848211070940. doi: 10.1177/17562848211070940
De Gregorio, Michael, Lee, Tanya, Krishnaprasad, Krupa, Amos, Gregory, An, Yoon-Kyo, Bastian-Jordan, Matthew, Begun, Jakob, Borok, Nira, Brown, Dougal J. M., Cheung, Wa, Connor, Susan J., Gerstenmaier, Jan, Gilbert, Lauren E., Gilmore, Robert, Gu, Bonita, Kutaiba, Numan, Lee, Allan, Mahy, Gillian, Srinivasan, Ashish, Thin, Lena, Thompson, Alexander J., Welman, Christopher J., Yong, Eric X. Z., De Cruz, Peter, van Langenberg, Daniel, Sparrow, Miles P. and Ding, Nik S. (2021). Higher anti-tumor necrosis factor-α levels correlate with improved radiological outcomes in Crohn's perianal fistulas. Clinical Gastroenterology and Hepatology, 20 (6), 1306-1314. doi: 10.1016/j.cgh.2021.07.053
Gilmore, Robert, Hilley, Patrick, Srinivasan, Ashish, Choy, Matthew and De Cruz, Peter (2021). Sequential use of high-dose tofacitinib after infliximab salvage therapy in acute severe ulcerative colitis. Journal of Crohn's and Colitis, 16 (1), 166-168. doi: 10.1093/ecco-jcc/jjab109
Gilmore, Robert, Hilley, Patrick, Srinivasan, Ashish, Choy, Matthew C., Grace, Josephine A. and de Cruz, Peter (2021). Tofacitinib Is Safe and Effective When Used in Combination With Infliximab for the Management of Refractory Ulcerative Colitis. Clinical Gastroenterology and Hepatology, 19 (6), 1302-1303. doi: 10.1016/j.cgh.2020.07.046
Hilley, Patrick, Gilmore, Robert, Srinivasan, Ashish, Choy, Matthew and De Cruz, Peter (2021). Combined targeted treatment using biologic-tofacitinib co-therapy in chronic active ulcerative colitis. Inflammatory Bowel Diseases, 27 (9), e105-e106. doi: 10.1093/ibd/izab095
Gilmore, Robert, Li Wai Suen, Christopher F D, Elliott, Tim, De Cruz, Peter and Srinivasan, Ashish (2020). Using Ustekinumab to Treat Crohn’s Disease–Related Orofacial Granulomatosis: Two Birds, One Stone. Inflammatory Bowel Diseases, 26 (8), e79-e80. doi: 10.1093/ibd/izaa123
Gilmore, Robert, Choy, Matthew C, Li Wai Suen, Christopher F D and De Cruz, Peter (2020). Letter to the Editor: Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial. Inflammatory Bowel Diseases, 26 (5), e41-e41. doi: 10.1093/ibd/izaa038
Conference Paper
Lim, E., Thai, M., Hendy, P., Alchlaihawi, M., Leong, R., Connor, S., Ng, W., Gu, B., van Langenberg, D., Thin, L., Schulberg, J., Kamm, M., Gilmore, R., Taylor, K., Sallis, O., Andrews, J., Daker, C., Barclay, M., Wark, G., Ghaly, S., Begun, M., Krishnaprasad, K. and Begun, J. (2019). Endoscopic balloon dilatation is safe and has a high success rate in patients with stricturing Crohn's disease. 14th Congress of ECCO, Copenhagen, Denmark, 6-9 March 2019. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjy222.647